Cargando…
Doubling of serum creatinine and the risk of cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes mellitus: a cohort study
BACKGROUND: Doubling of serum creatinine is often used as a marker for worsening kidney function in nephrology trials. Most people with chronic kidney disease die of other causes before reaching end-stage renal disease. We were interested in the association between doubling of serum creatinine and t...
Autores principales: | Schneider, Cornelia, Coll, Blai, Jick, Susan S, Meier, Christoph R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910685/ https://www.ncbi.nlm.nih.gov/pubmed/27354825 http://dx.doi.org/10.2147/CLEP.S107060 |
Ejemplares similares
-
Cataract in patients with diabetes mellitus—incidence rates in the UK and risk factors
por: Becker, Claudia, et al.
Publicado: (2018) -
Cancer risk in patients with chronic obstructive pulmonary disease
por: Schneider, Cornelia, et al.
Publicado: (2010) -
Salivary Creatinine Estimation as an Alternative to Serum Creatinine in Chronic Kidney Disease Patients
por: Venkatapathy, Ramesh, et al.
Publicado: (2014) -
Correlation of Ultrasonographic Parameters with Serum Creatinine in Chronic Kidney Disease
por: Siddappa, Jagdeesh K., et al.
Publicado: (2013) -
Effect of Pemafibrate on Serum Creatinine in Patients with Chronic Kidney Disease
por: Imai, Enyu, et al.
Publicado: (2022)